Sirolimus-eluting stents are more effective than bare stents for the prevention of coronary artery restenosis in patients with de novo lesions

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1426, 2004-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with sirolimus-eluting stents is effective in patients with unprotected left main coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2209-2220

Informa Healthcare

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1431-1434

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus-eluting stent superior for coronary artery restenosis prevention

By  

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite